Antibody responses against B-cell epitopes of the hypervariable region 1 of hepatitis C virus in self-limiting and chronic human hepatitis C followed-up using consensus peptides

Journal of Medical Virology

Volumn 66, Issue 2, 2002, Pages 204-217

  Isaguliants, Maria G ^a   Widell, Anders ^b   Zhang, Shumin M ^c   Sidorchuk, Anna ^c   Levi, Michael ^d   Smirnov, Valerii D ^e   Santantonio, Teresa ^a   Diepolder, Helmut M ^a   Pape, Gerd R ^a   Nordenfelt, Erik ^a  

^a SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

^b D I IVANOVSKY INSTITUTE OF VIROLOGY   (Russian Federation)

^c LUND UNIVERSITY HOSPITAL   (Sweden)

^d UNIVERSITY OF BARI   (Italy)

^e UNIVERSITY OF MUNICH   (Germany)

Author keywords

Antibody response kinetics; Chronic; HCV HVR1 amino acid consensus; Prediction of clearance; Self limited

Indexed keywords

EPITOPE; HYPERVARIABLE REGION; UNCLASSIFIED DRUG; VIRUS GLYCOPROTEIN;

ADULT; AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ANTIGEN ANTIBODY REACTION; ARTICLE; CARBOXY TERMINAL SEQUENCE; CHRONIC HEPATITIS; CLINICAL ARTICLE; DNA SEQUENCE; FEMALE; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; SEQUENCE ANALYSIS; SYMPTOMATOLOGY;

ADULT; AMINO ACID SEQUENCE; CONSENSUS SEQUENCE; EPITOPES, B-LYMPHOCYTE; FEMALE; HEPACIVIRUS; HEPATITIS C; HEPATITIS C ANTIBODIES; HEPATITIS C, CHRONIC; HUMANS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; PEPTIDES; VIRAL PROTEINS;

HEPATITIS C VIRUS;

EID: 0036137073     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmv.2131     Document Type: Article

References (36)

1. Patients infected with the same hepatitis C virus strain display different kinetics of the isolate-specific antibody response
2. Antibody responses to the hepatitis C virus E2 protein: Relationship to viremia and prevalence in anti-HCV seronegative subjects
3. Limited humoral immunity in hepatitis C virus infection
4. Immunobiology of hepatitis C virus (HCV) infection: The role of CD4 T cells in HCV infection
5. Prevention of HCV infection of chimpanzees by hyperimmune serum against the hypervariable region of the envelope protein
6. Solid phase peptide synthesis utilizing 9fluorenylmethoxycarbonyl amino acids
7. Hepatitis C virus lacking the hypervariable region 1 of the second envelope protein is infectious and causes acute resolving or persistant infection in chimpanzees
8. + T cells
9. Immunogenic properties of reverse transcriptase of HIV-1 assessed by DNA and protein immunization of rabbits
10. Reactivity of synthetic pepotides representing selected sections of hepatitis C virus core and envelope proteins with a panel of hepatitis C virus-seropositive human plasma
11. Humoral immune response to hypervariable region of the putative envelope glycoprotein (gp70) of hepatitis C virus
12. Genetic drift in hypervariable region of the viral genome in persistent hepatitis C virus infection
13. Antibody response to E2/NS1 hepatitis C virus protein in patients with acute hepatitis C
14. Hypervariable region of hepatitis C virus envelope glycoprotein (E2 NS1) in an agammaglobulinemic patient
15. The kinetics of antibodies against hepatitic C virus may predict viral clearance in exposed hemophiliacs
16. Evolution of hypervariable region 1 of hepatitis C virus in primary infection
17. Long-term evolution of the hypervariable region of hepatitis C virus in a common-sourceinfected cohort
18. B-cell epitopes in hypervariable region 1 of hepatitis C virus obtained from patients with chronic persistent hepatitis
19. Variation of HCV virus hypervariable region 1 in immunocomromised patients
20. Conformational conservation and basic character of the hypervariable region 1 (HVR1) of Hepatitis C virus E2 envelope glycoprotein. Clues for HVR1 biological role
21. Expression and purification of the recombinant polypeptide containing antigenic determinants of the core protein of hepatitis C virus
22. Towards a solution for the hepatitis C virus hypervariability: Mimotopes of the hypervariable region 1 can induce antibodies cross-reacting with a large number of viral variants
23. Immunodominant regions within the hepatitis C virus core and putative matrix proteins
24. Occurence of antibodies reactive with more than one variant of the putative envelope glycoprotein (gp70) hypervariable region 1 in viremic hepatitis C virus-infected patients
25. Neutralizing antibodies against hepatitis C virus and the emergence of neutralization escape mutant viruses
26. T cell recognition of hypervariable region 1 from hepatitis C virus envelope protein with multiple class II MHC molecules in mice and humans: Preferential help for induction of antibodies to the hypervariable region
27. B-cell epitopes in HIV-1 Tat and Rev proteins colocolize with T-cell epitopes and with functional domains
28. Mapping major and minor T-cell epitopes in vitro and their immunogenic or tolerogenic effect in vivo in non-human primates
29. The hypervariable region 1 protein of hepatitis C virus broadly reactive with sera of patients with chronic hepatitis C has a similar amino acid sequence with the consensus sequence
30. Evidence for immune selection of hepatitis C virus (HCV) putative envelope glycoprotein variants: Potential role in chronic HCV infections
31. Hepatitis C virus RNA in blood donor sera detected by the polymerase chain reaction: Comparison with supplementary hepatitis C antibody assays
32. Typing of Hepatitis c virus using specific primers in a modified PCR based assay. Epidemiological applications
33. At least three different hepatitis C virus strains implicated in Swedish and Danish patients with intravenous immunoglobulin associated hepatitis C
34. Distinguishing acute from symptomatic chronic hepatitis C virus (HCV) infection by site-directed serology of the HCV structural proteins
35. Antibodies in human sera specific to hypervariable region 1 of HCV can block viral attachment
36. Epitope mapping of antibodies directed against hypervariable region 1 in acute self-limiting and chronic infections due to hepatitic C virus